Koninklijke Philips NV
PHG
ISIN null / Valor 1107280
Koninklijke Philips NV
UMushroom community rating:
About company
Koninklijke Philips NV is a globally recognized leader in health technology, focusing on the development and manufacturing of medical devices, diagnostic imaging systems, patient monitoring solutions, and health informatics platforms. Headquartered in the Netherlands, Philips aims to enhance people's health and well-being by providing innovative technologies that span the entire healthcare continuum, from preventive care and diagnosis to treatment and home health management. The company serves a diverse range of customers, including hospitals, healthcare professionals, and consumers, leveraging its expertise to improve clinical outcomes, operational efficiency, and the overall quality of life. Philips continuously invests in research and development to drive advancements in healthcare technology, ensuring it remains at the forefront of the industry.
Summarized from source with an LLMView SourceSector: TechnologyLatest Results (29.08.2026):
Koninklijke Philips NV — Q2 2026: Philips reported Q2 2026 sales of EUR 4.4 billion with comparable sales up 4% versus the prior year; adjusted EBITA was EUR 717 million, lifting the adjusted EBITA margin to about 16.4%. The quarter also highlights ongoing innovation and sustainability metrics alongside workforce and impact measures.
Sales
Reported sales were EUR 4.4 billion in Q2 2026.
Comparable sales growth
Comparable sales increased 4% in Q2 2026, driven by growth across all segments.
Profitability (Adjusted EBITA)
Adjusted EBITA was EUR 717 million in Q2 2026, with the adjusted EBITA margin improving to approximately 16.4%.
Impact and reach
Philips reports "lives improved" at 2 billion (as presented in the Q2 2026 at-a-glance summary), reflecting its stated reach and impact of products and partnerships.
Sustainability
Full value chain carbon emissions for Q2 2026 were reported at 887 kilotonnes CO₂‑e (covering scope 1, 2 and material scope 3 categories).
Employees
Headcount was about 64,000 employees (63,670 full-time equivalents) at the end of Q2 2026.
Summarized from source with an LLMView SourceKey figures
Performance
Volatility
24397 M
Market cap (USD)
707,823
Daily traded volume (Shares)
25.455 / 25.18
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
EQUITIES OF THE SAME SECTOR
